Top Midwest universities line up for 2020 Drug Development conference

Comments (0) News

OMAHA, Neb. (February 11, 2020)—With eight months before the third MidWest Drug Development Conference opens its doors, 11 Universities are already lined up to participate in the two-day event.

So far, the impressive list of participating institutions are:

  • Mayo Clinic
  • Ohio State University
  • Purdue University
  • University of Colorado Anchutz Medical Campus
  • University of Iowa
  • University of Kansas
  • University of Kentucky
  • University of Missouri
  • University of Nebraska Medical Center
  • University of Oklahoma
  • WARF (Wisconsin Alumni Research Foundation)

Each participating institution will highlight new therapeutics they are developing. All told, the two-day conference will feature about 40 therapeutics during 10-minute presentations. Specific details about those presentations are not yet available, but a list of previous technology presentation titles can he viewed here: https://www.mwdrugdevelopment.com/previoustechnologies/.

The 11 institutions account for a massive amount of research and innovation in the region, according to the latest data from the Association of University Technology Managers, or AUTM for short. In 2018 the participating universities spent a combined $6.05 billion in research, which led to 2,625 new inventions. The 11 schools secured 685 U.S. patents, produced 186 new products and formed 89 startup companies. They also signed 998 licensing agreements, 25 of which were worth more than $1 million each.

Additional institutions will likely join the list in the coming weeks.

Another key feature of the conference are one-on-one partnering meetings between researchers, tech transfer professionals, industry representatives, investors and other interested parties. Previous attendees have included representatives from such companies as AbbVie Ventures, Atlas Ventures, GlaxoSmithKline, Merck and Pfizer, to name a few.

The conference begins on Monday, Oct. 5, and concludes the following day, Tuesday, Oct. 6. It will be at the Capital District Marriott in downtown Omaha.

Cost is $500 per ticket, but organizers will waive a limited number of registration fees for those who represent pharmaceutical and biotech companies and investment groups. Contact conference organizers to learn how to receive a waiver code. Register here: https://www.mwdrugdevelopment.com/tickets/.

A full list of participating universities—and the technologies they plan to present—will soon be announced.

Read article

Virtual Incision raises $20 million for surgical robot

Comments (0) News, Success Stories

Virtual Incision MIRA

LINCOLN, Nebraska (January 8, 2020)—Virtual Incision, a surgical robotics startup, recently closed a Series B+ round of financing worth $20 million, the company announced today.

The funds will help push Virtual Incision’s surgical robot through what might be the last regulatory hurdles before the robot can be used in human patients in the United States.

University of Nebraska-Lincoln robotics engineer Shane Farritor, Ph.D., and University of Nebraska Medical Center surgeon Dmitry Oleynikov, M.D., co-founded Virtual Incision. Their collaboration has built a surgical device that expects to take what were once open, highly invasive surgeries and transform them into minimally invasive, or laparoscopic, procedures.

Virtual incision’s initial robotic design is called the MIRA Surgical Robotic Platform. MIRA stands for “miniaturized in vivo robotic assistant.”

Weighing about two pounds, MIRA has a decided advantage over other robotic platforms, which require the dedicated space of an entire room.

Virtual Incision’s robot, however, could easily move from one room to another, even for complex procedures such as a colon resection.

Colon resections involve a surgeon using a large incision to remove a portion of a patient’s lower intestine. Such procedures often require months of recovery and rehabilitation. But when performed as a minimally invasive procedure—such as with Virtual Incision’s one-of-a-kind robot—that recovery time would be better measured in days.

“Beyond our initial device design for colon resection, Virtual Incision has begun developing a family of procedure-specific mini-robots for additional operations such as hernia repair, gallbladder removal and others, potentially enabling millions more surgical procedures each year,” Farritor said in the announcement.

Said Oleynikov: “We are focused on expanding access to minimally invasive robotic procedures and delivering this innovation to the many centers where a smaller, simpler and less costly solution is needed.”

Bluestem Capital led the funding round, along with PrairieGold Venture Partners and Genesis Innovation Group.

According to the press release, Virtual Incision plans to file for an Investigational Device Exemption with the FDA. If approved, the company can then start a “confirmatory clinical study” that will “evaluate the safety and efficacy of the MIRA platform for colon resection surgeries in patients at a number of U.S. investigational sites.”

Including the most recent raise, Virtual Incision has now attracted more than $50 million in investments since its initial founding in 2006.

Read article

Date set, registration open for 2020 MidWest Drug Development Conference

Comments (0) News

Two-day event returns on Oct. 5-6

OMAHA, Nebraska (January 6, 2020)—Due the continued success and popularity of the MidWest Drug Development Conference, the event will return for a third year and registrations are now open, planners announced today.

The conference will again span two days, featuring Midwestern university technologies, beginning on Monday, Oct. 5, and concluding the following day, Tuesday, Oct. 6. The same venue—the Capital District Marriott in downtown Omaha—will house the event.

Register here for the 2020 MidWest Drug Development conference. Cost is $500 per ticket, but a limited number of registration fees will be waved for attendees that represent pharmaceutical firms, investment groups or other parties interested in supporting early-stage therapeutics. Contact conference organizers to learn how to receive a waiver code.

The list of participating universities has not yet been released, but a mix of returning and new institutions are expected, planners said.

“We had another great turn-out, and interest seems to grow each year,” primary organizer Matt Boehm said. “We long suspected there might be a need for this type of event, and this has been demonstrated by its continued popularity among participating universities as well as pharmaceutical companies and investment groups.”

With the dates and venue set for 2020, universities and other research institutes are invited to apply for inclusion among a limited supply of coveted presentation slots. A list of participating universities will be announced soon, Boehm said.

Subscribe here to receive updates about participating schools and other important news related to the 2020 MidWest Drug Development Conference.

Last year, a dozen universities presented 42 new, drug-related technologies in short, 10-minutes packages. The audience was a collection of pharmaceutical companies, biotech companies, venture capital groups and other potential partners who could help further develop those new technologies.

In previous years, participating institutions included Colorado, Colorado State, Iowa, Iowa State, Kansas, Kansas State, Mayo Clinic, Missouri, Nebraska, Notre Dame, Ohio State, Oklahoma, Purdue, South Dakota, Wisconsin’s WARF, and Washington University in St. Louis.

Last year’s group alone accounted for more than a combined $6.65 billion in research expenditures and 2,875 new inventions in 2017, according to the most recent data available.

All told, 111 people attended the two-day conference in 2019, including representatives from 30 companies and investment groups. About 240 one-on-one partnering meetings were scheduled over the two-day conference.

Read article

Free workshop planned for SBIR/STTR funding

Comments (0) News

Royalty Distribution

OMAHA, Neb. (January 2, 2020)—The NIH and 10 other federal agencies have additional grant funding available to translate commercially viable research and innovation. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs were designed to help further academic and entrepreneurial innovation.

An up-coming workshop at UNMC’s Durham Research Center I, in room 1006, will help guide attendees on how to take advantage of those programs. The workshop primarily targets faculty, students, postdocs, clinicians and early-stage life science companies.

Divided into two parts, the two-day workshop begins on Jan. 30 with “Part 1: Proposal Prep for NIH.” The first part begins at 8:30 a.m. and concludes at 5 p.m.

The first day will cover detailed instructions on how to produce more competitive grant proposals for the NIH’s SBIR/STTR program. It is expected to cover all the basics, plus how to meet reviewer expectations while avoiding common pitfalls.

The next day, on Jan. 31, the workshop wraps up with “Part 2: Commercialization Planning for SBIR/STTR Proposals.” The second part also begins at 8:30 a.m., but concludes at noon.

SHARPhub logoThe second day will focus on the how-to’s of evaluating a startup’s potential market, developing a strong commercialization plan and attracting SBIR/STTR funding across all agencies, including NIH.

Registration for the workshop is free, and attendees may attend one or both days. More information and registration details are on the event website: https://www.sharpideahub.com/event/ne0120/

Becky Aistrup

Becky Aistrup

Becky Aistrup, MBA, a managing partner at BBC Entrepreneurial Training & Consulting (BBCetc) will present the workshop.

Aistrup is a regular speaker at national conferences and often reviews proposals for NSF, DOE, and USDA. She also holds SBIR/STTR-related training for BBCetc, offering specialized expertise in the DoD, NIH, NASA, and DHS programs. Her professional background includes more than 30 years of experience in the medical, biotech, advanced materials and electronics industries.

BBCetc’s SHARPhub program sponsors the workshop. Created in 2018, the Sustainable Heartland Accelerator Regional Partnership (SHARP) Hub helps fast-track early-stage life science technologies into startup companies to develop commercial products and services. The SHARPhub was made possible by an STTR grant from the NIH to advance research and development toward commercialization in Nebraska, Kansas, Oklahoma and the Dakotas.

UNMC and its technology transfer office, UNeMed, are among SHARPhub’s sponsors. UNeMed is also the technology transfer and commercialization office for UNO.

Read article

The year in review: Highlights from 2019

Comments (0) Blog

It’s time again to look back at the last calendar year, review highlights and reflect on some of the more important stories, developments and most popular posts from 2019.

1. Innovation Week

Benson Edagwa, Ph.D., (left) chats with colleagues during the 2019 Innovation Awards ceremony on Thursday, Oct. 17. Later in the evening, Dr. Edagwa was named the 2019 Emerging Inventor.

Innovation Week continues its reign as the most well-traveled sector of the UNeMed website. Innovation Week is an annual showcase for all UNMC and UNO innovations and their inventive faculty, students and staff. As is growing custom, the story announcing the major award winners was among the most popular individual news stories of the year. The awards highlighted researchers Benson Edagwa, Ph.D., and Corey Hopkins, Ph.D., with top honors.

Dr. Edagwa was the 2019 Emerging Inventor of the year for his innovations in the development of long-acting antiretroviral therapies. He was an inventor on 11 new inventions submitted in the last five years, and was a key member of the team that created “LASER ART,” which is short for Long-Acting Slow Effective Release Antiretroviral Therapy. (See below.)

Dr. Hopkins took home the Most Promising New Invention Award for his work on a novel series of phosphodiesterase 4 (PDE4B) specific inhibitors. The inhibitors show immense promise in treating inflammatory diseases such as chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, atopic dermatitis, inflammatory bowel disease, and central nervous system diseases that include addiction, schizophrenia and neurodegenerative diseases.

Finally, UNeTech presented inventor Jason Johanning, M.D., and his startup company, FutureAssure, with the “Startup of the Year” award. Dr. Johanning built FutureAssure around a device he invented as way to accurately measure a patient’s risk in surgery.

Scott Mulder (left) and Quinn Nelson during the 2019 Tech Transfer Boot Camp.

2. Boot Camp 2019

UNeMed offered its fourth Technology Transfer Boot Camp this summer, which presented an exclusive opportunity for students to learn more about what it takes to successfully commercialize a new invention.

3. Product Pipeline

In April 2018, UNeMed’s product pipeline was a new feature, and has been a popular landing spot ever since. The pipeline highlights selected technologies and where they fit in the development cycle, whether they’re still in the prototype phase, clinical trials or as a product currently available in the marketplace.

Ron Allen

4. Ron Allen, 73

Just days into 2019 we lost one of our favorite people, Ron Allen. As Joe Runge put it in his touching tribute: “Ron’s accomplishments, which could fill three full lives, were not just a bullet list on a resume. They were the results of a life lived in that generous and open state of mind. I am grateful to have met him and for all I learned about the FDA and design controls. I hope that his generosity and excitement will stay with me longest.”

5. UNMC research hints toward HIV cure, breaks internet

When UNMC researcher Howard Gendelman, M.D., announced that an HIV cure wasn’t just possible, but likely, the news exploded across the internet and airwaves for the better part of two days. There’s still an awful lot that needs to happen before we see this new treatment in the clinic, but as far as we know, this is the first time that science showed that an HIV cure was anything more than a pipedream.

6. UNeMed featured in halftime radio show

Susan Fritz, the interim president of the University of Nebraska, sat down with UNeMed President and CEO Michael Dixon during the halftime radio show of Nebraska’s football contest with the Wisconsin Badgers.

7. MidWest Drug Development Conference

The MidWest Drug Development Conference, organized and orchestrated by Matt Boehm, entered its second year. It was unquestioningly another success, and because of that—you heard it here first—there will be a third.

8. UNeTech lands $750,000 matching federal grant

UNeTech, a University institute designed to identify and nurture promising startup companies, landed a major grant award for a project they are calling the Omaha Medical Technology Pipeline. UNeTech will work with UNMC, UNO, Metro Community College, the Nebraska Business Development Center and the Omaha Chamber of Commerce to help establish high-growth, high-tech biomedical industry in the region.

9. Andersen lands national honor: Golden Stopwatch award

UNeMed contract specialist Jeff Andersen meets with guests during the 2016 UNMC Technology Demonstration Day on Oct. 5.

Our most recent news item turned out to be among our most popular, and deservedly so. Contracts Specialist Jeff Andersen was singled out with the Golden Stopwatch Award for his rapid turnaround times in processing material transfer agreements. Andersen was one of 37 tech transfer professionals around the world to receive the award, which was presented by Addgene, an international plasmid repository based in Massachusetts.

10. UNeMed releases 2019 annual report

In something of a surprise, the announcement of the 2019 annual report rounds out our top 10. The report featured a comic book inspired theme, and detailed all of UNeMed’s accomplishments and core metrics from the previous fiscal year.

Classics
Several posts from previous years remain popular and relevant:
1. The importance of technology transfer
2. How to determine who is an inventor on a patent: Unraveling inventorship vs. authorship
3. Veins and arteries are just pipes, right?
4. Technology transfer 101: Defining research commercialization
5. Five important aspects of copyrights that you should know

Read article

Andersen lands national honor: Golden Stopwatch Award

Comments (0) News

UNeMed contracts specialist Jeff Andersen meets with guests during the 2016 UNMC Technology Demonstration Day.

UNeMed contracts specialist Jeff Andersen meets with guests during the 2016 UNMC Technology Demonstration Day.

OMAHA, Nebraska (Dec. 5, 2019)—UNeMed contracts specialist Jeff Andersen earned national recognition recently with a Golden Stopwatch Award.

“It’s an area that doesn’t often get much attention, but Jeff Andersen has quietly become one of the best contracting managers in the nation,” UNeMed president and CEO Michael Dixon said. “His customer service and turn-around time on MTAs (material transfer agreements) and CDAs (confidential disclosure agreements) is outstanding.”

Presented by Addgene, the Golden Stopwatch Award recognizes technology transfer professionals for “outstanding” turnaround times in processing MTAs. Addgene is a major international plasmid repository based in Watertown, Massachusetts.

This is Addgene’s first year presenting the awards. In all, 37 tech transfer agents around the world received the honor.

“The best thing about receiving the award is that it is a reflection of our great team here at UNeMed,” Andersen said. “My colleagues here are a true asset – I couldn’t do it without them. The open lines of communication and the spirit of teamwork here at the office allow us to keep things on track and provide high quality service to our university, its faculty and its staff, which, at the end of the day, is our ultimate goal”

An MTA is a legal contract commonly prepared, reviewed and processed by tech transfer and commercialization offices, such as UNeMed. MTAs document the transfer of tangible research materials between institutions. These tangible research materials are usually biological materials, such as plasmids, cell lines, mice strains, or human tissue, but may also include non-biological materials as well.

MTAs allow scientists to obtain these essential research materials from other institutions, but they set forth parameters under which the research materials may be used. Ideally, MTA parameters protect the interests of both parties, while ensuring adherence to applicable institutional and legal requirements. Parameters may include terms related to confidentiality obligations, duration of use, the type of use, ownership of intellectual property arising from the use, publication of results, warranty, liability, or compliance with applicable laws.

On average, Andersen and UNeMed field about 358 MTAs each year. Since Andersen joined UNeMed in January 2015, UNeMed has processed about 1,458 MTAs.

In the fiscal year ending in 2019, UNeMed processed 344 MTA requests. The company record is 390, set in 2017.

Read article

MidWest Drug Development Conference hits the mark again

Comments (0) News

OMAHA, Nebraska (November 18, 2019)—The second MidWest Drug Development conference held last month was another resounding success.

The conference featured 42 technology presentations from 18 Midwestern universities, and 30 different companies and investor groups. An estimated 240 one-on-one partnering meetings were held during the two-day event, opening the door to additional opportunities for each participating university.

“I know we got a lot of value out of the conference, and I’ve had nothing but positive feedback from just about everyone I talked to,” said Matt Boehm, the event coordinator and director of licensing for UNeMed, the technology transfer and commercialization office for the University of Nebraska Medical Center. UNeMed is also the primary sponsor and host of the event.

Boehm added that he sat in on 17 one-on-one partnering meetings during the event, resulting in ongoing conversations that may yet lead to further development.

“That’s exactly what we want this conference to do,” UNeMed president and CEO Michael Dixon said. “New therapies, treatments and cures are the kind of things that can grow out of those deeper conversations. And, honestly, I think there’s a huge blind spot for the innovation that happens in the Midwest, and we really want this conference to help change that. Not just for us in Nebraska, but for all our friends in the region.”

Meet new partners, unearth hidden gems at the Midwest Drug Development Conference in Omaha, Nebraska, Sept. 30-Oct. 1, 2019. Seventeen major Midwest medical research institutions with their best and brightest technologies will be in one place, including Cincinnati Children's Hospital, Mayo Clinic, Colorado, Iowa, Kansas State, Purdue, Notre Dame, Ohio State, Kansas, Kentucky, Missouri, Nebraska, Oklahoma, South Dakota, Toledo and Wisconsin (WARF). Those institutions accounted for (according to 2017 AUTM data): $6.65 billion in research 2,815 new inventions 950 licensing agreements 768 U.S. patents 153 new products 117 startups formed 25 blockbusters (licensing agreements worth $1 million or more)

All told, an estimated 111 people attended the conference. About half were researchers, inventors and other University representatives. The remainder were largely representatives of pharmaceutical companies, biotech companies or venture capital groups.

Among the represented pharmaceutical companies were Pfizer, Merck, GlaxoSmithKline, Johnson & Johnson, Boehringer Ingelheim and Otsuka. Among the represented venture capital firms were Atlas Ventures, Abbvie Ventures, Rivervest Ventures and 5AM  Ventures.

The mix of attendees created an ideal environment for University innovators to meet and build new relationships with industry, according to comments provided by conference goers who participated in a post-event survey.

“This is the single most important partnering event to cover academic institutions across the Midwest,” said an industry representative who attended the event.

Attendees from the university side were equally positive about the event.

“We have entered into early licensing negotiations will nearly all of the connections made at MWDDC,” said one University representative. “The opportunity to share portfolios and initiate conversations has been very valuable, leading to on-going discussions on a number of technologies.”

Another University representative added: “To a person, the industry people I talked with—both in one-on-one meetings and in casual conversations—stated that they valued the chance to meet in one place; the number of tech transfer offices; and to see the number, variety, and breadth of technologies to which they were exposed.”

The participating universities and research institutions were Cincinnati Children’s Hospital, Colorado, Iowa, Kansas, Kansas State, Kentucky, Mayo Clinic, Missouri, Missouri-Kansas City, Nebraska, Notre Dame, Ohio State, Oklahoma, Purdue, South Dakota, Toledo and Wisconsin.

Organizers are looking at hosting the 2020 MidWest Drug Development Conference again next October, and will finalize plans in the coming months.

 

This slideshow requires JavaScript.

Read article

UNeMed will be featured in halftime radio show

Comments (0) News

Michael DixonLINCOLN, Nebraska (Nov. 15, 2019)—UNeMed President and CEO, Michael Dixon, Ph.D., will be the featured guest during the University of Nebraska President’s Halftime Show of the Cornhuskers’ football game with the No. 14 Wisconsin Badgers on Saturday.

The game kickoffs in Lincoln at 11 a.m., and the radio broadcast will be carried on the Husker IMG Sports Network, which can be heard in Omaha on 590 AM. A list of additional IMG affiliates can be found here.

Interim President Susan Fritz, Ph.D., is expected to explore entrepreneurship and innovation at the University during a five-minute interview with Dr. Dixon and host Greg Sharpe, the Voice of the Huskers.

The show will look at the various tools the University provides for entrepreneurs throughout the state, and examine the value of innovations developed at the University, and how they might impact not just Nebraskans, but people everywhere.

*UPDATE (Nov. 18, 2019): Listen to the full interview here. (https://nebraska.edu/-/media/projects/unca/audio/president-fritz/president-halftime-interview–wisconsin-11162019.mp3?la=en)

 

Read article

Edagwa, Hopkins, Johanning headline top awards

Comments (1) Innovation Week, News

Benson Edagwa, Ph.D., (left) chats with colleagues during the 2019 Innovation Awards ceremony on Thursday, Oct. 17. Later in the evening, Dr. Edagwa was named the 2019 Emerging Inventor.

OMAHA, Neb. (October 18, 2019)—Innovation Week concluded last night with the 2019 Research Innovation Awards Banquet.

UNMC researchers Benson Edagwa, Ph.D., and Corey Hopkins, Ph.D., were presented the top honors and highlighted the 13th installment of UNeMed’s awards program. Vascular surgeon and Professor Jason Johanning, M.D., was also singled out with a special award.

Sponsored and hosted by UNeMed, the awards program specifically recognizes UNMC and UNO innovators and their work, conferring awards to those who have disclosed a new invention, were issued a United States patent, or had their technology licensed for further commercial development.

The awards ceremony honored a new innovation from Dr. Hopkins as the Most Promising New Invention, and Dr. Edagwa was named the Emerging Inventor. Dr. Johnanning’s FutureAssure was named UNeTech’s Startup of the Year.

From left are Chancellor Jeffrey Gold, M.D., Corey Hopkins, Ph.D., and UNeMed President and CEO, Michal Dixon, Ph.D. Dr. Hopkins’ PDE4B Selective Inhibitors was named UNeMed’s Most Promising New Invention of the year during the 2019 Innovation Awards ceremony on Thursday, Oct. 17.

Dr. Hopkins is developing a novel series of inhibitors that hold promise as treatments for several inflammatory diseases, including chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, atopic dermatitis and inflammatory bowel disease. His inhibitors, which target phosphodiesterase 4 or PDE4, also show promise in central nervous system diseases like schizophrenia, neurodegenerative diseases and even drug addiction.

Dr. Edagwa was the 2019 Emerging Inventor in recognition of his contributions to innovations in the development of long-acting antiretroviral therapies.

From left are Chancellor Jeffrey Gold, M.D., Benson Edagwa, Ph.D., and UNeMed President and CEO, Michal Dixon, Ph.D. Dr. Edagwa was named UNeMed’s Emerging Inventor of the year during the 2019 Innovation Awards ceremony on Thursday, Oct. 17.

Since he joined UNMC in 2012, Dr. Edagwa has been an inventor on 11 inventions, including three in the last year. He is also a listed inventor on 11 pending patent applications. Most of his work centers on improvements to treating HIV and Hepatitis B, and is a key inventor of LASER ART (long acting slow effective antiretroviral therapy). LASER ART shows great promise as a treatment that could be given to HIV patients once every six months or even just once a year. LASER ART was also a key component in a recent study led by Howard Gendelman, M.D., that appeared to eradicate HIV from mice—a scientific first.

From left are Chancellor Jeffrey Gold, M.D., Jason Johanning, M.D., and UNeMed President and CEO, Michal Dixon, Ph.D. Dr. Johanning’s startup company, FutureAssure, was named UNeTech’s Startup of the Year during the 2019 Innovation Awards ceremony on Thursday, Oct. 17..

Dr. Johanning created his startup, FutureAssure, on the foundation of a device he invented that will help measure a patient’s risk in surgery. The device gives medical teams objective measures to assess that risk and eventually improve outcomes and surgical safety.

The evening also featured a keynote speaker, noted chemist Dennis Liotta, Ph.D. He is the Executive Director for the Emory Institute for Drug Development at Emory University, and helped transform HIV/AIDS from a death sentence into a chronic but manageable infection.

It is estimated that about 90 percent of all HIV-infected patients in the United States have taken one of the two drugs he invented.

Dennis Liotta, Ph.D., delievered a noon presentation to an estimated 140 on Thursday, Oct. 17, as a part of Innovation Week 2019. He also delevered the keynote address during the Innovation Awards banquet later that evening.

Dr. Liotta talked about his long road toward a blockbuster drug development that spanned more than 15 years, but ultimately resulted in a $525 million in royalties to Emory University in 2005.

“This looks like the bottom line. This looks like the end of the story, but it’s not,” Dr. Liotta said.

The money only lasts so long, and it’s important to have the infrastructure of support so that large-impact developments can happen more often, he said.

Earlier in the day, at noon, Dr. Liotta hosted a well-attended seminar entitled: “Novel Therapeutics for Treating Viral Diseases, Cancer and Inflammatory Disorder.” The presentation was a scientific look at his more current work, including an algorithmic system called FRESH. It uses machine learning to help discover more promising new drug candidates.

The awards banquet later that evening was the culmination of Innovation Week, an annual celebration that promotes and recognizes innovation and research at UNMC and UNO.

Innovation Week began Monday with a Kick-Off event, and then on Tuesday UNeTech, the University’s startup incubator, hosted an open house. On Wednesday, Nebraska Bio sponsored its popular annual event, a luncheon and panel discussion that celebrates women in STEM fields—science, technology, engineering and mathematics.

Learn more about Innovation Week and UNeMed at https://unemed.com/innovation-week.

2019 Innovation Awards Program by UNeMed Corporation on Scribd

Read article

Liotta talk, awards close out I-week today

Comments (0) Innovation Week, News

OMAHA, Neb. (October 17, 2019)—Innovation Week concludes today with a noon seminar from a world-renowned researcher, followed by the anticipated awards ceremony later this evening.

Dr. Liotta

At noon, noted chemist Dennis Liotta, Ph.D., will lead a one hour seminar in the DRC auditorium. He is the Executive Director for the Emory Institute for Drug Development, and helped transform HIV/AIDS from a death sentence into a chronic but manageable infection.

It is estimated that about 90 percent of all HIV-infected patients in the United States have taken one of the two drugs he invented. The title of his seminar, which is free and open to all: “Novel Therapeutics for Treating Viral Diseases, Cancers and Inflammatory Disorders.”

Pizza will be provided first-come, first-served.

The week culminates later tonight with an awards program that specifically recognizes innovators and their work, conferring awards to those who have disclosed a new invention, were issued a United States patent, or had their technology licensed for further commercial development.

The awards program is invitation only.

UNeMed’s Innovation Week is an annual celebration that promotes and recognizes innovation and research at UNMC and UNO.

Innovation Week began Monday with a Kick-Off event, and then on Tuesday UNeTech, the University’s startup incubator, hosted an open house. Finally, on Wednesday, Nebraska Bio sponsored its popular annual event, a luncheon and panel discussion that celebrates women in STEM fields—science, technology, engineering and mathematics.

Learn more about Innovation Week and UNeMed at https://unemed.com/innovation-week.

Read article

Women in STEM luncheon is today

Comments (0) News

OMAHA, Neb. (October 16, 2019)—Innovation Week continues today at a luncheon and panel discussion that celebrates Nebraska women in science, technology, engineering and math, or STEM for short.

Sponsored and hosted by Bio Nebraska, the luncheon will be held at 11 a.m.-2 p.m. in the Empire Room at Midtown Crossing in Omaha. Registrations are now closed.

The planned speakers are Nancy Williams—co-founding President and CEO of No More Empty Pots—and Shonna Dorsey, senior IT consultant for Mutual of Omaha.

Innovation Week is an annual celebration that promotes and recognizes innovation and research at UNMC and UNO, and is sponsored by UNeMed.

Remaining events include a seminar about breakthrough HIV treatments from a world-renowned academic researcher, and the annual awards ceremony.

On Thursday, Oct. 17, at noon, world-renowned researcher and chemist, Dennis Liotta, Ph.D., will lead a one hour seminar. He is the Executive Director for the Emory Institute for Drug Development, and helped transform HIV/AIDS from a death sentence into a chronic but manageable infection. It is estimated that about 90 percent of all HIV-infected patients in the United States have taken one of the two drugs he invented. The title of his seminar, which is free and open to all: “Novel Therapeutics for Treating Viral Diseases, Cancers and Inflammatory Disorders.”

Dr. Liotta

The seminar will be held in the DRC auditorium, beginning at noon. Pizza will be provided first-come, first-served.

The week culminates Thursday evening with an awards program that specifically recognizes innovators and their work, conferring awards to those who have disclosed a new invention, were issued a United States patent, or had their technology licensed for further commercial development.

The awards program is invitation only.

Innovation Week began Monday with a Kick-Off event, and then on Tuesday UNeTech, the University’s startup incubator, hosted an open house.

Learn more about Innovation Week and UNeMed at https://unemed.com/innovation-week.

Read article

UNeTech Open House is tonight

Comments (0) Innovation Week, News

OMAHA, Neb. (October 15, 2019)—Innovation Week continues today when UNeTech, the University’s startup incubator, hosts an open house beginning at 4 p.m.

The Open House will feature local entrepreneurs who will demonstrate early-stage technologies that are the basis for new startup companies in healthcare-related industries. It will be held at UNeTech at 3929 Harney Street.

Sponsored by UNeMed, Innovation Week is an annual celebration that promotes and recognizes innovation and research at UNMC and UNO.

Other events include a seminar about breakthrough HIV treatments from a world-renowned academic researcher; a luncheon panel discussion; and an awards ceremony.

On Wednesday, Oct. 16, Bio Nebraska will sponsor a luncheon and panel discussion that celebrates Nebraska women in STEM—science, technology, engineering and math. It will be held at 11 a.m.-2 p.m. in the Empire Room at Midtown Crossing in Omaha. Registrations for that event are now closed.

Dr. Liotta

On Thursday, Oct. 17, at noon, world-renowned researcher and chemist, Dennis Liotta, Ph.D., will lead a one hour seminar. He is the Executive Director for the Emory Institute for Drug Development, and helped transform HIV/AIDS from a death sentence into a chronic but manageable infection. It is estimated that about 90 percent of all HIV-infected patients in the United States have taken one of the two drugs he invented. The title of his seminar, which is free and open to all: “Novel Therapeutics for Treating Viral Diseases, Cancers and Inflammatory Disorders.”

The seminar will be held in the DRC auditorium, beginning at noon. Pizza will be provided first-come, first-served.

The week culminates Thursday evening with an awards program that specifically recognizes innovators and their work, conferring awards to those who have disclosed a new invention, were issued a United States patent, or had their technology licensed for further commercial development.

The awards program is invitation only.

Innovation Week began Monday with a Kick-Off event that featured complimentary coffee and other giveaways. There, guests met with UNeMed staff, and learned more about how UNeMed can help inventors develop their innovations.

Learn more about Innovation Week and UNeMed at https://unemed.com/innovation-week.

Read article

UNeMed hosts 2019 Boot Camp

Comments (0) News

by Catherine Murari-Kanti, UNeMed | October 14, 2019

Scott Mulder (left) and Quinn Nelson discuss their project during the 2019 Tech Transfer Boot Camp at the University of Nebraska Medical Center. Boot Camp is hosted by UNeMed, the tech transfer and commercialization office for UNMC and the University of Nebraska at Omaha.

Medical students, graduate students and research technicians and scientists from UNMC, UNO and UNL filled out UNeMed’s fourth Technology Transfer Boot Camp, held Aug. 12-16, 2019. The Boot Camp provides a comprehensive understanding of technology transfer and research commercialization.

Catherine Murari-Kanti, Ph.D., (right) leads the UNeMed’s Tech Transfer Boot Camp. At left is UNeMed intern A.J. Crawford.

A combination of classroom instruction and interactive team-based activities allowed the students to experience what it would be like to work in a technology transfer office. They evaluated real inventions and performed prior art searches while learning to navigate intellectual property law, technology marketing, contract negotiation and entrepreneurship. They worked as teams to develop marketing strategies, draft confidential and non-confidential invention summaries and participate in mock licensing negotiations. At the end of the Boot Camp, each team presented their findings to the UNeMed team, and the UNeMed team, in turn, quizzed the students about their conclusions.

The UNeMed Boot Camp provides an option for graduate students looking into alternative career options, and helps prepare them for better internship opportunities at university technology transfer offices or business development positions in industry.

The 2019 Boot Camp garnered enough interest from University faculty that UNeMed is considering plans for a faculty-only technology transfer workshops in 2020. If you are interested, please reach out to Catherine Murari-Kanti at catherine.murari@unmc.edu.

Read article

UNeMed releases 2019 annual report

Comments (0) News

OMAHA, Nebraska (Oct. 14, 2019)—UNeMed released today its 2019 annual report, which details UNeMed’s key metrics, and highlights notable achievements during the fiscal year ending in 2019.

In an open letter to readers, UNeMed President and CEO Michael Dixon, Ph.D., highlights the addition of new tools available to UNeMed staffers as they help commercialize and transfer University-born innovation into the public sector.

Last year, UNeMed built a new conference that sought use the collective power of the region as a way to leverage more interest and engagement from pharmaceutical companies and investor groups. The MidWest Drug Development Conference, was “a resounding success,” Dixon said.

The conference played a large role in grant support from SHARPhub, which uses NIH money to provide entrepreneurial resources to researchers in the Midwest. SHARPhub is short for Sustainable Heartland Accelerator Regional Partnership, and is available in North Dakota, South Dakota, Nebraska, Kansas and Oklahoma.

“SHARPhub will provide the kind of support that UNMC and UNO startups might need to be more competitive for venture or SBIR funding,” Dixon said, “or it might help provide support for additional development of new technology.”

Dixon also highlighted the growth of UNeTech as a biomedical startup accelerator in the region.

“UNeTech can be a place where biomedical entrepreneurs can move past their origin stories to develop products that have a national and global impact on human health,” Dixon said.

The annual report offers more details on the Drug Development Conference, and also highlights the Innovation Overground, a tech transfer podcast UNeMed launched in July 2018. The report also details the 2018 Innovation Awards banquet, and the more recent news about Howard Gendleman, M.D., and his team’s breakthrough with HIV.

Finally, several key technologies currently available for licensing are also included in the report.

The report can be viewed online, and printed copies are also available. Contact UNeMed to receive a free printed copy.

 

2019 UNeMed Annual Report by on Scribd

Read article

Innovation Week kicks off today

Comments (0) Innovation Week, News

OMAHA, Neb. (October 14, 2019)—Innovation Week opens today with a Kick-Off event at the Durham Research Center atrium at 9-11a.m.

The Kick-Off will feature complimentary coffee and doughnuts, along with free UNeMed T-shirts and other giveaways. Guests are invited to meet with UNeMed staff, and learn more about how UNeMed can help inventors develop their innovations.

UNeMed’s Innovation Week is an annual celebration that promotes and recognizes innovation and research at UNMC and UNO.

Other events include an open house of local early-stage startup companies; a seminar about breakthrough HIV treatments from a world-renowned academic researcher; and a luncheon panel discussion.

On Tuesday, Oct. 15, the University’s startup incubator, UNeTech, will host an open house. Beginning at 4 p.m., local entrepreneurs will demonstrate early-stage technologies that are the basis for new startup companies in healthcare-related industries. The open house will be held at UNeTech at 3929 Harney Street.

On Wednesday, Oct. 16, Bio Nebraska will sponsor a luncheon and panel discussion that celebrates Nebraska women in STEM—science, technology, engineering and math. It will be held at 11 a.m.-2 p.m. in the Empire Room at Midtown Crossing in Omaha. Registrations for that event are now closed.

Dr. Liotta

On Thursday, Oct. 17, at noon, world-renowned researcher and chemist, Dennis Liotta, Ph.D., will lead a one hour seminar. He is the Executive Director for the Emory Institute for Drug Development, and helped transform HIV/AIDS from a death sentence into a chronic but manageable infection. It is estimated that about 90 percent of all HIV-infected patients in the United States have taken one of the two drugs he invented. The title of his seminar, which is free and open to all: “Novel Therapeutics for Treating Viral Diseases, Cancers and Inflammatory Disorders.”

The seminar will be held in the DRC auditorium, beginning at noon. Pizza will be provided first-come, first-served. The event is open and free to everyone.

The week culminates Thursday evening with an awards program that specifically recognizes innovators and their work, conferring awards to those who have disclosed a new invention, were issued a United States patent, or had their technology licensed for further commercial development.

The awards program is invitation only.

Learn more about Innovation Week and UNeMed at https://unemed.com/innovation-week.

 

Read article

Innovation Week 2019 starts Monday

Comments (0) Innovation Week, News

OMAHA, Neb. (October 9, 2019)—Innovation Week, an annual celebration that promotes and recognizes innovation and research at UNMC and UNO, begins on Monday.

Events include a kick-off to meet UNeMed staff; an open house of local, early-stage startup companies; a seminar about breakthrough HIV treatments from a world-renowned academic researcher; and a luncheon panel discussion.

Innovation Week opens on Monday, Oct. 14, with a Kick-Off at the Durham Research Center atrium at 9-11a.m. The Kick-Off will feature complimentary coffee and doughnuts, along with free UNeMed T-shirts and other giveaways. Guests are invited to meet with UNeMed staff, and learn more about how UNeMed can help inventors develop their innovations.

Dr. Liotta

The week will be highlighted on Thursday, Oct. 17, at noon with a one-hour seminar from world-renowned researcher and chemist, Dennis Liotta, Ph.D. He is the Executive Director for the Emory Institute for Drug Development, and helped transform HIV/AIDS from a death sentence into a chronic but manageable infection. It is estimated that about 90 percent of all HIV-infected patients in the United States have taken one of the two drugs he invented. The title of his seminar, which is free and open to all: “Novel Therapeutics for Treating Viral Diseases, Cancers and Inflammatory Disorders.”

The seminar will be held in the DRC auditorium, beginning at noon. Pizza will be provided first-come, first-served.

On Tuesday, Oct. 15, the University’s startup incubator, UNeTech, will host an open house. Beginning at 4 p.m., local entrepreneurs will demonstrate early-stage technologies that are the basis for new startup companies in healthcare-related industries. The open house will be held at UNeTech at 3929 Harney Street.

On Wednesday, Oct. 16, Bio Nebraska will sponsor a luncheon and panel discussion that celebrates Nebraska women in STEM—science, technology, engineering and math. It will be held at 11 a.m.-2 p.m. in the Empire Room at Midtown Crossing in Omaha. To book one of the last few remaining seats, register before the close of business on Friday: https://www.bionebraska.org/women-in-stem.aspx.

The week culminates Thursday evening with an awards program that specifically recognizes innovators and their work, conferring awards to those who have disclosed a new invention, were issued a United States patent, or had their technology licensed for further commercial development.

The awards program is invitation only.

Learn more about Innovation Week and UNeMed at https://unemed.com/innovation-week.

Read article